Related Experiment Video
Updated: May 25, 2026

12:59
Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
Published on: September 26, 2013
IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors
Terhi Savinko1, Sampsa Matikainen, Ulpu Saarialho-Kere
1Unit of Immunotoxicology, Finnish Institute of Occupational Health, Helsinki, Finland.
The Journal of Investigative Dermatology
|January 27, 2012
Summary
Interleukin-33 (IL-33) and its receptor ST2 are upregulated in atopic dermatitis (AD) skin, suggesting a key role in the inflammatory skin condition. Their expression is influenced by various triggers and suppressed by tacrolimus.
Area of Science:
- Immunology
- Dermatology
- Molecular Biology
Background:
- Atopic dermatitis (AD) involves T-helper type 2 (Th2) cytokine-driven skin inflammation.
- Interleukin-33 (IL-33) is a cytokine produced by barrier tissues that activates Th2 lymphocytes, mast cells, and eosinophils.
- IL-33 signaling occurs via a receptor complex including ST2 and IL-1RAcP.
Purpose of the Study:
- To investigate the expression of IL-33 and its receptor components (ST2, IL-1RAcP) in human AD skin and relevant models.
- To explore the cellular sources and regulation of IL-33 production in skin.
- To assess the impact of topical tacrolimus on IL-33/ST2 expression in AD.
Main Methods:
- Analysis of IL-33 and ST2 expression in human AD skin biopsies.
- Examination of IL-33/ST2 in a murine model of AD (filaggrin-deficient mice).
- In vitro studies using skin fibroblasts, keratinocytes, macrophages, and endothelial cells to assess IL-33 production.
- Evaluation of the effect of topical tacrolimus on IL-33/ST2 expression.
Main Results:
- Increased expression of IL-33 and ST2 was observed in human AD skin following allergen or staphylococcal enterotoxin B (SEB) exposure.
- Elevated IL-33 and ST2 levels were found in the skin of filaggrin-deficient mice, a model for AD.
- Fibroblasts, keratinocytes, macrophages, and endothelial cells produced IL-33 upon stimulation with TNF-α, IFN-γ, and double-stranded RNA.
- Topical tacrolimus treatment reduced the increased expression of IL-33 and ST2 induced by irritants, allergens, or SEB.
Conclusions:
- The IL-33/ST2 interaction plays a significant role in the pathogenesis of atopic dermatitis.
- Bacterial and viral infections may contribute to increased IL-33 production in AD.
- Targeting the IL-33/ST2 pathway could be a potential therapeutic strategy for AD.
Related Concept Videos
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...